The purpose of this study is to evaluate the Temple Touch Pro (TTP) in Pediatric Intensive Care Unity (PICU) patients requiring targeted temperature control.

The study evaluates the use of Temple Touch Pro (TTP), a noninvasive method of measuring core temperature, in critical care pediatric patients that require targeted temperature management. These patients currently require two probes placed in the following locations to appropriately control the temperature therapy: esophageal, bladder, and/or rectum.

Both the bladder and rectum locations have limitations and risks that Temple Touch Pro could address. Following patient screening and consent, Temple Touch Pro (TTP) will be added as a third temperature monitoring modality.

Inclusion Criteria:

1. Age 0 to less than 18 years of age
2. PICU Diagnosis requiring targeted temperature management. For example traumatic brain injury, cardiac arrest, or anoxic brain injury
3. Requires continuous temperature monitoring with a foley catheter (bladder) or a general purpose probe placed in the esophagus.
4. Enrolled within 24 hours of start of continuous temperature monitoring.
5. Patient has adequate forehead space to accommodate the TTP sensor
6. Temporal artery perfusion not compromised by injury or other pathology
7. No surgical procedure planned for 72 hours
8. Targeted temperature management expected for at least 24 hours at time of consent

Exclusion Criteria:

1. Already enrolled in another trial addressing temperature management
2. Allergy to medical grade acrylic adhesive
3. Patient does not tolerate placement of TTP sensor on forehead
4. Contraindication to the placement of two or more of Foley, esophageal, and rectal temperature probes.
5. A history of skin irritation, skin sensitivity, or skin disease, including psoriasis, eczema, atopic dermatitis, and skin cancer.
6. Pregnant or lactating female